Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 253

1.

Reply to Tosh et al.: Quantitative analyses of cultural evolution require engagement with historical and archaeological research.

Currie TE, Turchin P, Whitehouse H, François P, Feeney K, Mullins D, Hoyer D, Collins C, Grohmann S, Savage P, Mendel-Gleason G, Turner E, Dupeyron A, Cioni E, Reddish J, Levine J, Jordan G, Brandl E, Williams A, Cesaretti R, Krueger M, Ceccarelli A, Figliulo-Rosswurm J, Tuan PJ, Peregrine P, Marciniak A, Preiser-Kapeller J, Kradin N, Korotayev A, Palmisano A, Baker D, Bidmead J, Bol P, Christian D, Cook C, Covey A, Feinman G, Júlíusson ÁD, Kristinsson A, Miksic J, Mostern R, Petrie C, Rudiak-Gould P, Ter Haar B, Wallace V, Mair V, Xie L, Baines J, Bridges E, Manning J, Lockhart B, Bogaard A, Spencer C.

Proc Natl Acad Sci U S A. 2018 Jun 14. pii: 201807312. doi: 10.1073/pnas.1807312115. [Epub ahead of print] No abstract available.

PMID:
29903903
2.

Emergent Presentation of an Adult with Undiagnosed Coarctation of the Aorta.

Armistead S, Mullins D, Sherick S, Ashurst J.

Case Rep Emerg Med. 2018 Feb 19;2018:5756983. doi: 10.1155/2018/5756983. eCollection 2018.

3.

A novel image processing-based system for turbidity measurement in domestic and industrial wastewater.

Mullins D, Coburn D, Hannon L, Jones E, Clifford E, Glavin M.

Water Sci Technol. 2018 Mar;77(5-6):1469-1482. doi: 10.2166/wst.2018.030.

PMID:
29528334
4.

Harnessing innate lung anti-cancer effector functions with a novel bacterial-derived immunotherapy.

Bazett M, Costa AM, Bosiljcic M, Anderson RM, Alexander MP, Wong SWY, Dhanji S, Chen JM, Pankovich J, Lam S, Sutcliffe S, Gunn H, Kalyan S, Mullins DW.

Oncoimmunology. 2017 Nov 27;7(3):e1398875. doi: 10.1080/2162402X.2017.1398875. eCollection 2018.

5.

Quantitative historical analysis uncovers a single dimension of complexity that structures global variation in human social organization.

Turchin P, Currie TE, Whitehouse H, François P, Feeney K, Mullins D, Hoyer D, Collins C, Grohmann S, Savage P, Mendel-Gleason G, Turner E, Dupeyron A, Cioni E, Reddish J, Levine J, Jordan G, Brandl E, Williams A, Cesaretti R, Krueger M, Ceccarelli A, Figliulo-Rosswurm J, Tuan PJ, Peregrine P, Marciniak A, Preiser-Kapeller J, Kradin N, Korotayev A, Palmisano A, Baker D, Bidmead J, Bol P, Christian D, Cook C, Covey A, Feinman G, Júlíusson ÁD, Kristinsson A, Miksic J, Mostern R, Petrie C, Rudiak-Gould P, Ter Haar B, Wallace V, Mair V, Xie L, Baines J, Bridges E, Manning J, Lockhart B, Bogaard A, Spencer C.

Proc Natl Acad Sci U S A. 2018 Jan 9;115(2):E144-E151. doi: 10.1073/pnas.1708800115. Epub 2017 Dec 21.

6.

Not just Salk.

Greider C, Hopkins N, Steitz J, Amon A, Asai D, Barres B, Bass B, Bassler B, Birgeneau R, Bjorkman P, Botchan M, Brugge J, Cech T, Colwell R, Craig N, deLange T, Eisen M, Gottesman S, Green R, Handelsman J, Kimble J, King MC, Lehmann R, Marder E, Mullins D, O'Shea E, Schmid S, Seydoux G, Spradling A, Storz G, Szostak J, Telesnitsky A, Tilghman S, Tjian R, Vale R, Wolberger C, Zakian V.

Science. 2017 Sep 15;357(6356):1105-1106. doi: 10.1126/science.aao6221. No abstract available.

PMID:
28912235
7.

CXCR3+ monocytes/macrophages are required for establishment of pulmonary metastases.

Butler KL, Clancy-Thompson E, Mullins DW.

Sci Rep. 2017 Mar 30;7:45593. doi: 10.1038/srep45593.

8.

Systematic Pan-Cancer Analysis Reveals Immune Cell Interactions in the Tumor Microenvironment.

Varn FS, Wang Y, Mullins DW, Fiering S, Cheng C.

Cancer Res. 2017 Mar 15;77(6):1271-1282. doi: 10.1158/0008-5472.CAN-16-2490. Epub 2017 Jan 26.

9.

Psychotropic Medication Use among Medicare Beneficiaries Following Traumatic Brain Injury.

Albrecht JS, Mullins DC, Smith GS, Rao V.

Am J Geriatr Psychiatry. 2017 Apr;25(4):415-424. doi: 10.1016/j.jagp.2016.11.018. Epub 2016 Dec 28.

10.

Diphosphine-Protected Au22 Nanoclusters on Oxide Supports Are Active for Gas-Phase Catalysis without Ligand Removal.

Wu Z, Hu G, Jiang DE, Mullins DR, Zhang QF, Allard LF Jr, Wang LS, Overbury SH.

Nano Lett. 2016 Oct 3. [Epub ahead of print]

PMID:
27685318
11.

Cryptosporidium parvum Infection Following Contact with Livestock.

Suler D, Mullins D, Rudge T, Ashurst J.

N Am J Med Sci. 2016 Jul;8(7):323-5. doi: 10.4103/1947-2714.187162.

12.

Adaptive immunity programmes in breast cancer.

Varn FS, Mullins DW, Arias-Pulido H, Fiering S, Cheng C.

Immunology. 2017 Jan;150(1):25-34. doi: 10.1111/imm.12664. Epub 2016 Sep 20. Review.

13.

Topical treatment of melanoma metastases with imiquimod, plus administration of a cancer vaccine, promotes immune signatures in the metastases.

Mauldin IS, Wages NA, Stowman AM, Wang E, Olson WC, Deacon DH, Smith KT, Galeassi N, Teague JE, Smolkin ME, Chianese-Bullock KA, Clark RA, Petroni GR, Marincola FM, Mullins DW, Slingluff CL Jr.

Cancer Immunol Immunother. 2016 Oct;65(10):1201-12. doi: 10.1007/s00262-016-1880-z. Epub 2016 Aug 13.

14.

Intratumoral interferon-gamma increases chemokine production but fails to increase T cell infiltration of human melanoma metastases.

Mauldin IS, Wages NA, Stowman AM, Wang E, Smolkin ME, Olson WC, Deacon DH, Smith KT, Galeassi NV, Chianese-Bullock KA, Dengel LT, Marincola FM, Petroni GR, Mullins DW, Slingluff CL Jr.

Cancer Immunol Immunother. 2016 Oct;65(10):1189-99. doi: 10.1007/s00262-016-1881-y. Epub 2016 Aug 13.

15.

Childhood-Diagnosed ADHD, Symptom Progression, and Reversal Learning in Adulthood.

McCarthy H, Stanley J, Piech R, Skokauskas N, Mulligan A, Donohoe G, Mullins D, Kelly J, Johnson K, Fagan A, Gill M, Meaney J, Frodl T.

J Atten Disord. 2018 Apr;22(6):561-570. doi: 10.1177/1087054716661233. Epub 2016 Aug 9.

PMID:
27507767
16.

Supercooling Points of Murgantia histrionica (Hemiptera: Pentatomidae) and Field Mortality in the Mid-Atlantic United States Following Lethal Low Temperatures.

DiMeglio AS, Wallingford AK, Weber DC, Kuhar TP, Mullins D.

Environ Entomol. 2016 Oct;45(5):1294-1299. Epub 2016 Aug 6.

PMID:
27497116
17.

The mitogen-activated protein kinase pathway plays a critical role in regulating immunological properties of BRAF mutant cutaneous melanoma cells.

Whipple CA, Boni A, Fisher JL, Hampton TH, Tsongalis GJ, Mellinger DL, Yan S, Tafe LJ, Brinckerhoff CE, Turk MJ, Mullins DW, Fadul CE, Ernstoff MS.

Melanoma Res. 2016 Jun;26(3):223-35. doi: 10.1097/CMR.0000000000000244.

PMID:
26974965
18.

Discovery of aminoquinazoline derivatives as human A(2A) adenosine receptor antagonists.

Zhou G, Aslanian R, Gallo G, Khan T, Kuang R, Purakkattle B, De Ruiz M, Stamford A, Ting P, Wu H, Wang H, Xiao D, Yu T, Zhang Y, Mullins D, Hodgson R.

Bioorg Med Chem Lett. 2016 Feb 15;26(4):1348-54. doi: 10.1016/j.bmcl.2015.11.048. Epub 2015 Dec 1.

PMID:
26781932
19.

Cold Tolerance of Halyomorpha halys (Hemiptera: Pentatomidae) Across Geographic and Temporal Scales.

Cira TM, Venette RC, Aigner J, Kuhar T, Mullins DE, Gabbert SE, Hutchison WD.

Environ Entomol. 2016 Apr;45(2):484-91. doi: 10.1093/ee/nvv220. Epub 2016 Jan 7.

PMID:
26744454
20.

Integrative analysis of breast cancer reveals prognostic haematopoietic activity and patient-specific immune response profiles.

Varn FS, Andrews EH, Mullins DW, Cheng C.

Nat Commun. 2016 Jan 4;7:10248. doi: 10.1038/ncomms10248.

21.

Frequency and characteristics of goal attainment following BoNT-A injection for management of spasticity.

Mullins D, Winter A, Fini N, Dixon C, Aldous S, Palit M, Holland AE.

Disabil Rehabil. 2016 Sep;38(19):1927-33. doi: 10.3109/09638288.2015.1107781. Epub 2015 Dec 30.

PMID:
26714558
22.

The Suitability of End Point Designs for Health Technology Assessment in Chronic Pain Studies.

Rycroft CE, Hirst M, Dunlop WC, Pirk O, Mullins D, Akehurst R.

Value Health. 2015 Dec;18(8):987-93. doi: 10.1016/j.jval.2015.07.001. Review.

23.

Site-Specific Immunomodulator: A Novel Treatment for Crohn's Disease.

Bressler B, Bethel KP, Kleef R, Reynolds SL, Sutcliffe S, Mullins DW, Gunn H.

Gastroenterol Res Pract. 2015;2015:231243. doi: 10.1155/2015/231243. Epub 2015 May 12.

24.

Use of molecular modeling aided design to dial out hERG liability in adenosine A(2A) receptor antagonists.

Deng Q, Lim YH, Anand R, Yu Y, Kim JH, Zhou W, Zheng J, Tempest P, Levorse D, Zhang X, Greene S, Mullins D, Culberson C, Sherborne B, Parker EM, Stamford A, Ali A.

Bioorg Med Chem Lett. 2015 Aug 1;25(15):2958-62. doi: 10.1016/j.bmcl.2015.05.036. Epub 2015 May 21.

PMID:
26048804
25.

Melanoma Induces, and Adenosine Suppresses, CXCR3-Cognate Chemokine Production and T-cell Infiltration of Lungs Bearing Metastatic-like Disease.

Clancy-Thompson E, Perekslis TJ, Croteau W, Alexander MP, Chabanet TB, Turk MJ, Huang YH, Mullins DW.

Cancer Immunol Res. 2015 Aug;3(8):956-67. doi: 10.1158/2326-6066.CIR-15-0015. Epub 2015 Jun 5.

26.

Fitness and physiology of Adelges tsugae (Hemiptera: Adelgidae) in relation to the health of the eastern hemlock.

Jones AC, Mullins DE, Brewster C, Rhea JP, Salom SM.

Insect Sci. 2016 Dec;23(6):843-853. doi: 10.1111/1744-7917.12240. Epub 2015 Sep 23.

PMID:
26013546
27.

The BRAF(V600E) inhibitor, PLX4032, increases type I collagen synthesis in melanoma cells.

Jenkins MH, Croteau W, Mullins DW, Brinckerhoff CE.

Matrix Biol. 2015 Oct;48:66-77. doi: 10.1016/j.matbio.2015.05.007. Epub 2015 May 16.

28.

Dyche Mullins: Finding filaments at the fringes.

Mullins D, Powell K.

J Cell Biol. 2015 Apr 13;209(1):4-5. doi: 10.1083/jcb.2091pi. No abstract available.

29.

Minimally invasive fluoroscopic percutaneous peritoneal dialysis catheter salvage.

Narayan R, Fried T, Chica G, Schaefer M, Mullins D.

Clin Kidney J. 2014 Jun;7(3):264-8. doi: 10.1093/ckj/sfu042.

30.

CXCR3 signaling in BRAFWT melanoma increases IL-8 expression and tumorigenicity.

Jenkins MH, Brinckerhoff CE, Mullins DW.

PLoS One. 2015 Mar 23;10(3):e0121140. doi: 10.1371/journal.pone.0121140. eCollection 2015.

31.

Physiology of environmental adaptations and resource acquisition in cockroaches.

Mullins DE.

Annu Rev Entomol. 2015 Jan 7;60:473-92. doi: 10.1146/annurev-ento-011613-162036. Review.

PMID:
25564743
32.

BRAF inhibition alleviates immune suppression in murine autochthonous melanoma.

Steinberg SM, Zhang P, Malik BT, Boni A, Shabaneh TB, Byrne KT, Mullins DW, Brinckerhoff CE, Ernstoff MS, Bosenberg MW, Turk MJ.

Cancer Immunol Res. 2014 Nov;2(11):1044-50. doi: 10.1158/2326-6066.CIR-14-0074. Epub 2014 Sep 2.

33.

Characterization of physical and chemical defenses in the hemlock woolly adelgid.

Jones AC, Mullins DE, Jones TH, Salom SM.

J Chem Ecol. 2014 Jun;40(6):560-8. doi: 10.1007/s10886-014-0453-x. Epub 2014 Jun 10.

PMID:
24913905
34.

Thiolate ligands as a double-edged sword for CO oxidation on CeO2 supported Au25(SCH2CH2Ph)18 nanoclusters.

Wu Z, Jiang DE, Mann AK, Mullins DR, Qiao ZA, Allard LF, Zeng C, Jin R, Overbury SH.

J Am Chem Soc. 2014 Apr 23;136(16):6111-22. doi: 10.1021/ja5018706. Epub 2014 Apr 15.

PMID:
24702268
35.

Characterization of a novel vasopressin V1b receptor antagonist, V1B-30N, in animal models of anxiety-like and depression-like behavior.

Hodgson RA, Mullins D, Lu SX, Guzzi M, Zhang X, Bleickardt CJ, Scott JD, Miller MW, Stamford AW, Parker EM, Varty GB.

Eur J Pharmacol. 2014 May 5;730:157-63. doi: 10.1016/j.ejphar.2014.02.027. Epub 2014 Mar 4.

PMID:
24602808
36.
37.

Effects of the selective adenosine A2A receptor antagonist, SCH 412348, on the parkinsonian phenotype of MitoPark mice.

Smith KM, Browne SE, Jayaraman S, Bleickardt CJ, Hodge LM, Lis E, Yao L, Rittle SL, Innocent N, Mullins DE, Boykow G, Reynolds IJ, Hill D, Parker EM, Hodgson RA.

Eur J Pharmacol. 2014 Apr 5;728:31-8. doi: 10.1016/j.ejphar.2014.01.052. Epub 2014 Jan 31.

PMID:
24486705
38.

Multiple murine BRaf(V600E) melanoma cell lines with sensitivity to PLX4032.

Jenkins MH, Steinberg SM, Alexander MP, Fisher JL, Ernstoff MS, Turk MJ, Mullins DW, Brinckerhoff CE.

Pigment Cell Melanoma Res. 2014 May;27(3):495-501. doi: 10.1111/pcmr.12220. Epub 2014 Mar 6. No abstract available.

39.

Characteristics, treatment, and health care expenditures of Medicare supplemental-insured patients with painful diabetic peripheral neuropathy, post-herpetic neuralgia, or fibromyalgia.

Johnston SS, Udall M, Alvir J, McMorrow D, Fowler R, Mullins D.

Pain Med. 2014 Apr;15(4):562-76. doi: 10.1111/pme.12328. Epub 2014 Jan 16.

PMID:
24433487
40.

Peptide vaccination in Montanide adjuvant induces and GM-CSF increases CXCR3 and cutaneous lymphocyte antigen expression by tumor antigen-specific CD8 T cells.

Clancy-Thompson E, King LK, Nunnley LD, Mullins IM, Slingluff CL Jr, Mullins DW.

Cancer Immunol Res. 2013 Nov;1(5):332-9. doi: 10.1158/2326-6066.CIR-13-0084.

41.

Species-specific inflammatory responses as a primary component for the development of glomerular lesions in mice and monkeys following chronic administration of a second-generation antisense oligonucleotide.

Frazier KS, Sobry C, Derr V, Adams MJ, Besten CD, De Kimpe S, Francis I, Gales TL, Haworth R, Maguire SR, Mirabile RC, Mullins D, Palate B, Doorten YP, Ridings JE, Scicchitano MS, Silvano J, Woodfine J.

Toxicol Pathol. 2014 Jul;42(5):923-35. doi: 10.1177/0192623313505781. Epub 2013 Nov 28.

PMID:
24292388
42.

Implementation of evidence-based employment services in specialty mental health.

Hamilton AB, Cohen AN, Glover DL, Whelan F, Chemerinski E, McNagny KP, Mullins D, Reist C, Schubert M, Young AS.

Health Serv Res. 2013 Dec;48(6 Pt 2):2224-44. doi: 10.1111/1475-6773.12115. Epub 2013 Oct 21.

43.

Attention network hypoconnectivity with default and affective network hyperconnectivity in adults diagnosed with attention-deficit/hyperactivity disorder in childhood.

McCarthy H, Skokauskas N, Mulligan A, Donohoe G, Mullins D, Kelly J, Johnson K, Fagan A, Gill M, Meaney J, Frodl T.

JAMA Psychiatry. 2013 Dec;70(12):1329-37. doi: 10.1001/jamapsychiatry.2013.2174.

PMID:
24132732
44.

Dementia in Down's syndrome: an MRI comparison with Alzheimer's disease in the general population.

Mullins D, Daly E, Simmons A, Beacher F, Foy CM, Lovestone S, Hallahan B, Murphy KC, Murphy DG.

J Neurodev Disord. 2013 Aug 20;5(1):19. doi: 10.1186/1866-1955-5-19.

45.

CO oxidation on supported single Pt atoms: experimental and ab initio density functional studies of CO interaction with Pt atom on θ-Al2O3(010) surface.

Moses-DeBusk M, Yoon M, Allard LF, Mullins DR, Wu Z, Yang X, Veith G, Stocks GM, Narula CK.

J Am Chem Soc. 2013 Aug 28;135(34):12634-45. doi: 10.1021/ja401847c. Epub 2013 Aug 16.

PMID:
23952672
46.

A2A receptor antagonists do not induce dyskinesias in drug-naive or L-dopa sensitized rats.

Jones N, Bleickardt C, Mullins D, Parker E, Hodgson R.

Brain Res Bull. 2013 Sep;98:163-9. doi: 10.1016/j.brainresbull.2013.07.001. Epub 2013 Jul 6.

PMID:
23838432
47.

Implementing a court diversion and liaison scheme in a remand prison by systematic screening of new receptions: a 6 year participatory action research study of 20,084 consecutive male remands.

McInerney C, Davoren M, Flynn G, Mullins D, Fitzpatrick M, Caddow M, Caddow F, Quigley S, Black F, Kennedy HG, O'Neill C.

Int J Ment Health Syst. 2013 Jun 25;7:18. doi: 10.1186/1752-4458-7-18. eCollection 2013.

48.

Pragmatic clinical trials: U.S. payers' views on their value.

Ratner J, Mullins D, Buesching DP, Cantrell RA.

Am J Manag Care. 2013 May 1;19(5):e158-65.

49.

Heterostructured BaSO4-SiO2 mesoporous materials as new supports for gold nanoparticles in low-temperature CO oxidation.

Tian C, Chai SH, Mullins DR, Zhu X, Binder A, Guo Y, Dai S.

Chem Commun (Camb). 2013 Apr 28;49(33):3464-6. doi: 10.1039/c3cc41167b.

PMID:
23511903
50.

Differential expression and tumor necrosis factor-mediated regulation of TNFRSF11b/osteoprotegerin production by human melanomas.

Oliver JL, Alexander MP, Norrod AG, Mullins IM, Mullins DW.

Pigment Cell Melanoma Res. 2013 Jul;26(4):571-9. doi: 10.1111/pcmr.12091. Epub 2013 Apr 11.

Supplemental Content

Loading ...
Support Center